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FGF activation was  tested  in bovine aortic endothelial  cells 
(BAECs)  following  transduction with different  amounts of 





















Validation of the sFGFR system. (A) sFGFR blocks FGF-induced Erk1/2 phosphorylation in vitro in a dose-dependent manner. Ad-GFP and 
Ad-sFGFR1IIIc were transduced in BAECs and stimulated with indicated concentration of FGF1 for 10 minutes. Total cell lysates were subjected 
to Western blotting. p-Erk1/2, phospho-Erk1/2; t-Erk1/2, total Erk1/2; VP, viral particles. (B) sFGFRs effectively inhibit FGF1-induced Erk1/2 
activation. Ad-Null, Ad-sFGFR1IIIc, Ad-sFGFR3IIIb, and Ad-sFGFR3IIIc were transduced in BAECs and stimulated with FGF1 for 5 minutes. 
(C) sFGFR3IIIb does not inhibit FGF2-induced Erk1/2 activation. Ad-Null and Ad-sFGFRs were transduced in BAECs and stimulated with FGF2 
for 5 minutes. (D) Plasma expression levels of sFGFR in mice. Ad-Null (control) or Ad-sFGFR1IIIc (5 × 1010 viral particles) was injected into 
C57BL/6 mice, and blood samples were taken at indicated time points. sFGFR levels were measured using an ELISA system detecting human 
IgG-Fc. Data are shown as mean ± SD, n = 4 in each group. (E) Tissue distribution of sFGFR. After 10 days of Ad-Null (control) or Ad-sFGFR1IIIc 
injection (5 × 1010 viral particles), tissue samples were collected and total protein was extracted. Thereafter, ELISA assays detecting human IgG-
Fc were performed. Data are shown as mean ± SD, 4 animals in each group. (F) Body weight change after injection of sFGFR. Ten-week-old 
C57BL/6 mice were injected with adenoviruses (5 × 1010 viral particles), and body weight was measured weekly. Data are shown as mean ± SD, 
n = 4 in each group. *P < 0.05, Student’s t test.
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Impaired vascular integrity in mice lacking FGF signaling. (A) Increased vascular permeability and impaired endothelial morphology in sFGFR1IIIc 
mouse. Ten days after adenoviral injection in C57BL/6 mice, the trachea vasculature was stained for CD31 (red). Green represents microspheres 
in the extravascular space. Scale bars: 20 μm (left panels); 10 μm (right panels). (B) sFGFR1IIIc increases vascular permeability in the muscle. 
Ad-Null (control) or Ad-sFGFR was injected in C57BL/6 mice, and 14 days later, Evans blue dye was injected i.v. The adductor group muscles 
were harvested for quantitation. Data are shown as mean ± SD (n = 4). *P < 0.05, control vs. sFGFR1IIIc by t test. (C) Inhibition of FGF signaling 
in the heart and lung increases vascular permeability. Ad-Null (control), Ad-sFGFR was injected in C57BL/6 mice, and 10 days later, Evans blue 
dye levels were examined in the heart and lung. Data are shown as mean ± SD for n = 7, control; n = 8, sFGFR1IIIc; n = 4, sFGFR3IIIb; n = 4, 
sFGFR3IIIc. *P < 0.05, vs. control by t test. (D) Increased vascular permeability in Ad-sFGFR1IIIc–treated nude mouse. NU/NU nude mice 
(Charles River Laboratories) were subjected to trachea CD31. Junctional CD31 staining observed in control (arrows) is completely absent in the 
Ad-sFGFR1IIIc–treated trachea vasculature. Scale bars: 20 μm (left panels); 10 μm (right panels). (E) Hemorrhage observed in Ad-sFGFR1IIIc–
treated mouse lung and heart. Ten days after adenoviral injection in nude mice, lung and heart were harvested for H&E staining. Upper panels 
show lung sections and lower panels show heart sections. Black arrows indicate myocardial hemorrhage. Original magnification, ×400.
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In vivo effect of FGF inhibition in the 
endothelium. (A) Enface prepara-
tion of the rat femoral artery trans-
duced with Ad-Null or Ad-FGFR1DN 
(109 PFUs). Segments of arteries 
were transduced with adenovi-
ruses and stained for VE-cadherin 
(red) and maximum intensity pro-
jection of 1-μm Z-Stack sections is 
shown. At day 5, endothelial cells 
lost cell-cell contacts and gaps 
formed between cells. Scale bars: 
10 μm. (B) Mouse carotid artery 
and jugular vein exposed to sys-
temic Ad-Null or Ad-sFGFR1IIIc 
viruses. Segments of arteries were 
stained for VE-cadherin, and maxi-
mum intensity projection of 1-μm 
Z-Stack sections is shown. Scale 
bars: 20 μm.
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monolayers  in  vitro.  Ad-GFP–expressing 














exposure  to  VEGF-A  markedly  decreased 
monolayer impedance. In contrast, exposure 
to FGF1 slightly but significantly increased 
impedance  (and  thus  reduced  permeabil-





























The  expression of N-cadherin, which  is  known  to  control 
VE-cadherin levels in endothelial cells, was not changed either 








Effect of FGF inhibition in the endothelium: electron microscopy analyses. (A) SEM analysis 
of rat femoral arteries transduced with Ad-Null. The arterial wall shows ridges formed due 
to contractions in the underlying smooth muscle cells (top panel, scale bar: 50 μm). Higher 
magnification detail of the Ad-Null–infected artery demonstrates the continuous endothelial 
monolayer (bottom panel, scale bar: 10 μm). (B) SEM analysis of Ad-FGFR1DN–trans-
duced rat femoral artery. The area with remaining endothelial cells is shown (left panels, 
scale bars: 50 μm [top]; 10 μm [bottom]). Endothelial cells are swollen and have lost con-
tacts with neighboring cells. Underlying matrix layer is partially exposed (white arrows). Area 
demonstrating severe loss of the endothelium with exposure of the subjacent basement 
membrane is also shown (right panels, scale bar: 50 μm [top]). Higher magnification shows 
a few cells, presumably platelets by size, adhering to the vessel wall (white arrowheads) 
(right panels, scale bar: 10 μm [bottom]). (C) Transmission electron microscopy analysis 
of Ad-Null–transduced rat femoral artery (day 2). Adjacent endothelial cells form a tightly 
sealed junction indicated by black arrows. Scale bar: 500 nm. (D) Ad-FGFR1DN–trans-
duced artery (day 1). Scale bar: 2 μm. Inset: a gap is formed between endothelial cells. 
Arrow (inset) indicates open cell-cell junction. Scale bar: 500 nm. (E) Ad-FGFR1DN–trans-
duced artery (day 2) shows an open endothelial junction (black arrows). A platelet (PLT) 
adheres to the open space and extends a cellular process (white arrowhead). Scale bar: 
500 nm. (F) Ad-FGFR1DN–transduced artery showing a wide gap in the endothelium (black 
arrow) and an EC detaching from the basement membrane. Scale bar: 2 μm.
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Increased endothelial permeability in cells lacking FGF signaling. (A) Endothelial monolayer permeability evaluated with ECIS system. Imped-
ance was measured every 5 minutes for 48 hours after the onset of adenoviral transduction. After adenoviral exposure, cell culture medium was 
changed to normal growth medium. n = 3 in each group, P < 0.05, control versus FGFR1DN or sFGFR1IIIc at 48 hours (B) ESIS analysis using 
various sFGFR adenoviruses. After adenoviral exposure, medium was replaced with normal growth medium. n = 3 in each group, P < 0.05, 
control versus sFGFR1IIIc or sFGFR3IIIc at 48 hours (C) Transwell tracer experiment using high (2 MDa) and low (70 kDa) molecular weight 
dextran. Full confluent BAECs on the Transwell chambers were transduced and dextrans were added in the upper chamber. Fluorescent val-
ues in the lower chamber were measured at indicated time points using a fluorescent microplate reader. Three independent experiments were 
performed. One representative experiment is shown as mean ± SD for n = 3 in each group; *P < 0.05 by Student’s t test, control vs. FGFR1DN. 
AU represents relative intensity of fluorescence. (D) Transwell tracer experiment using Ad-sFGFRs. Data are shown as mean ± SD for n = 3 in 
each group; *P < 0.05 by Student’s t test, control vs. sFGFR1IIIc.
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Junction proteins are absent from 
cell-cell contacts in cells lacking 
FGF signaling. (A) Immunostaining 
of quiescent and fully confluent 
endothelial monolayer. BAECs 
were transduced with Ad-GFP or 
Ad-FGFR1DN-GFP using low 
MOI (10 and 25, respectively) 
to limit the number of trans-
duced cells and minimize virus-
mediated toxicity. Cells were 
stained for VE-cadherin (red) 
and β-catenin (green) 24 hours 
later. The Ad-FGFR1DN-GFP 
vector has a bidirectional pro-
moter encoding both GFP and 
FGFR1DN, thus marking trans-
duced cells with GFP (shown in 
white). Note the loss of VE-cad-
herin and β-catenin staining at 
cell-cell contacts of FGFR1DN-
GFP–transduced cells. Arrow 
points to the gap between neigh-
boring FGFR1DN-GFP–trans-
duced cells. Scale bars: 20 μm. 
(B) Immunostaining of quiescent 
endothelial monolayer (BAECs) 
transduced with Ad-Null or Ad-
sFGFR1IIIc. Cells were stained 
for VE-cadherin (red), p120-
catenin (green), and DAPI (blue). 
sFGFR was secreted in the medi-
um; the effect is not limited to the 
transduced cells. Arrows indicate 
gaps between endothelial cells. 
Scale bars: 20 μm.
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Tight  junc t ion  and venous 
cells are similarly affected by 
FGF signaling inhibit ion. (A) 
Immunostaining of quiescent 
endothelial monolayer (BAECs) 
transduced with Ad-GFP or Ad-
FGFR1DN-GFP. Cells were stained 
for VE-cadherin (red) and ZO-1 
(green). The Ad-FGFR1DN-GFP 
vector has a bidirectional promoter 
encoding both GFP and FGFR1DN 
as described above (GFP signal 
is shown in white). Arrows indi-
cate reduced VE-cadherin and 
ZO-1 staining and gaps between 
endothelial cells. Scale bars: 20 μm. 
(B) Immunostaining of quiescent 
venous endothelial monolayer. 
HSVECs were transduced with 
Ad-GFP or Ad-FGFR1DN-GFP and 
stained for VE-cadherin (red) and 
p120-catenin (green) 24 hours later. 
Note loss of VE-cadherin and p120-
catenin staining at cell-cell contacts 
and formation of intercellular gaps 
of FGFR1DN-GFP–transduced cells 
(white arrows). Scale bars: 20 μm.
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FGF treatment maintains EC junctions and decreases endothelial 
permeability in vitro. (A) ECIS permeability assay using conflu-
ent monolayer. BAECs are matured to full confluency and the 
medium was replaced to 1% BSA in EBM-2 (Cambrex). FGF1 
(1 ng/ml) or 1% BSA/EBM-2 was added at the indicated time 
point (arrow). Six hours later, VEGF-A (25 ng/ml) or 1% BSA/
EBM2 was added at the indicated time point (arrow). At 6 hours, 
FGF treatment significantly increased monolayer impedance 
compared with the control treatment. (B) FGF treatment does 
not induce junction disruption on endothelial cell monolayers. 
BAECs are matured to full confluency, starved with 1% BSA in 
EBM-2 for 48 hours, and treated with either FGF1 (50 ng/ml) or 
VEGF (80 ng/ml) for 30 minutes Note with this condition, VEGF 
rapidly disrupts endothelial cell junctions (white arrows) whereas 
FGF treatment maintains junctions similar to those in the control 
monolayer. Scale bars: 20 μm.
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FGF dependence on VE-cadherin/p120-catenin interaction and VE-cadherin plasma membrane retention. (A) Decreased cell surface VE-cad-
herin in Ad-FGFR1DN–transduced BAECs. Quiescent BAECs were transduced with Ad-GFP or Ad-FGFR1DN and the monolayer was treated 
with biotin to label cell surface proteins. Biotinylated proteins were subjected to Western blot analysis and probed for VE-cadherin or N-cadherin. 
Total cell lysates from the same samples were also analyzed by Western blotting to evaluate total protein expression. (B) Western blot analy-
sis of expression of junction proteins. Transduced BAECs were harvested at the indicated time points, and total cell lysates were analyzed by 
Western blotting. (C) Effect of FGF treatment on VE-cadherin interaction with catenins. BAEC monolayers were maintained in 0.5% FBS basal 
medium for 24 hours and then stimulated with FGF1 (50 ng/ml) for the indicated times. Total cell lysates were immunoprecipitated with anti– 
VE-cadherin antibody and blotted with p120-catenin, β-catenin, or VE-cadherin antibody. (D) FGFR signaling requirement for VE-cadherin inter-
action with catenins. Subconfluent BAEC monolayer (~70% confluency) was transduced with Ad-GFP or Ad-FGFR1DN, and cells were grown 
to form mature junctions. At indicated time points, total cell lysates were prepared and immunoprecipitated with VE-cadherin antibody followed 
by immunoblotting with p120-catenin, β-catenin, or VE-cadherin antibody. As the monolayer forms mature junctions, VE-cadherin/p120-catenin 
interaction increases (Ad-GFP), whereas this interaction was decreased in Ad-FGFR1DN–treated cells. Nontransduced cells were treated with 
100 μM PV for 10 minutes prior to cell lysis, showing disrupted VE-cadherin/p120 interaction.
research article































































































  11. Eswarakumar, V.P.,  Lax,  I.,  and Schlessinger,  J. 
2005. Cellular signaling by fibroblast growth factor 
















Williams,  L.  1992.  A  truncated  form  of  fibro-














































































































































 53. Lee,  J.F.,  et  al.  2006. Dual  roles  of  tight  junc-
tion-associated protein, zonula occludens-1,  in 
sphingosine 1-phosphate-mediated endothelial 








gaps in venules. Am. J. Physiol. Heart Circ. Physiol. 
290:H107–H118.
